Skip to main content
ConductScienceScienceDex

Stanley R Hoffman

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #6,592
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1871172Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$2.8M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#6,592
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Stanley R Hoffman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Stanley R Hoffman as a PI. Multi-PI records show the full award amount for context.

  • 2R42HL167327-02R42Contact PI
    Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development: Phase II
    Fibrotherapeutics, Inc.
    $1.9M
    award amount
  • 1R44HL186828-01R44Co-investigator
    A Novel Water-Soluble, Orally-Active Peptide Therapeutic for Interstitial Lung Disease Derived from the Caveolin-1 Scaffolding Domain
    Fibrotherapeutics, Inc.
    $920.6K
    award amount

Award organization

Organizations that administered FY2026 awards listing Stanley R Hoffman as a PI.

FY2026 award administered by Fibrotherapeutics, Inc. (SC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Fibrotherapeutics, Inc.
  2. 2026
    $500K Cumulative Funding
  3. 2026
    $1M Cumulative Funding
  4. 2026
    $2M Cumulative Funding
  5. 2026
    Entered Top 50% Nationally
    Ranked #6592

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Stanley R Hoffman.

Dhandapani Kuppuswamy
Fibrotherapeutics, Inc.
1
shared award

Explore further

Find collaborators for Stanley R Hoffman

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →